Disclaimer: All authors declare that there are no beneficial arrangements with NovaLung® GmbH, Hechingen, Germany
In extracorporeal lung assist, membrane oxygenators are used to improve gas exchange. Accumulations on the membranes of coagulation end products can increase resistance to blood flow and diffusion distance. Thus, functioning of the system can be impaired and, in extreme cases, lead to malfunction which may necessitate change out of the oxygenator. We describe a method that complements conventional continuous heparinisation with the administration of acetylsalicylic acid to inhibit thrombocyte aggregation.Perfusion (2007) 22, 293—298.
Get full access to this article
View all access options for this article.
References
1.
Kopp R., Dembinski R., Kuhlen R.Role of extracorporeal lung assist in the treatment of acute respiratory failure . Minerva Anestesiol2006; 131(40): 587—95.
2.
Matheis G.New technologies for respiratory assist. Perfusion2003; 18(4): 245—51.
3.
Zwischenberger JBFuture of artificial lungs. Asaio J2004; 50(6): xlix-li.
4.
StammersAHFL, Christensen K, Deptula J, Sydzyik RT, Zavadil D, Willett L. Coagulopathic-induced membrane dysfunction during extracorporeal membrane oxygenation: a case report . Perfusion1997; 12(2): 143—49.
5.
Wendel HP, Philipp A., Weber N., Birnbaum DE, Ziemer G.Oxygenator thrombosis: worst case after development of an abnormal pressure gradient—incidence and pathway. Perfusion2001 Jul; 16(4): 271—78.
6.
Philipp A., Foltan M., Gietl M. et al. Interventionelle extrakorporale Lungenunterstützung (ILA) mittels arterio-venösem Shunt und einem neu entwickelten Low-Resistance Lunfg Assist Device (LAD)Kardiotechnik2003: 7—13.
7.
ECLS Registry Report: Extracorporeal Life Support Organization , 2006.
8.
Bein T., Weber F., Philipp A. et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med2006; 34: 1372—77.
9.
Murphy JA, Savage CM, Alpard SK et al. Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal. Perfusion2006; 16: 460—68.
10.
Glauber Msj , Senni M., Gamba A. et al. Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol. Int J Artif Organs1995; 18: 649—55.
11.
Syrbe G R H , Weidlich B., Ludwig J., Kopitzsch S., Gockefitz A., Herzog T.Individual dosing of ASA prophylaxis by controlling platelet aggregation. Clin Appl Thromb Hemost2001; 7: 209—13.
12.
Budde U.Aggregation of blood platelets by adenosine diphosphate and its reversal . Nature1962; 194: 927.
13.
Boru Gvr.Diagnose von Funktionsstörungen der Thrombozyten mit Hilfe der Aggregometrie . Hämostaseologie2002; 26: 564—71.
